G
Guido H.W. van Bogerijen
Researcher at University of Michigan
Publications - 19
Citations - 522
Guido H.W. van Bogerijen is an academic researcher from University of Michigan. The author has contributed to research in topics: Aortic dissection & Aneurysm. The author has an hindex of 11, co-authored 18 publications receiving 402 citations. Previous affiliations of Guido H.W. van Bogerijen include Utrecht University & University Medical Center Groningen.
Papers
More filters
Journal ArticleDOI
Predictors of aortic growth in uncomplicated type B aortic dissection
Guido H.W. van Bogerijen,Guido H.W. van Bogerijen,Guido H.W. van Bogerijen,Jip L. Tolenaar,Jip L. Tolenaar,Vincenzo Rampoldi,Frans L. Moll,Joost A. van Herwaarden,Frederik H.W. Jonker,Kim A. Eagle,Santi Trimarchi +10 more
TL;DR: Although conservative management remains indicated in uncomplicated ABAD, these patients might benefit from closer follow-up or early endovascular intervention, and several predictors might be used to identify those ABAD patients at high risk for aortic growth.
Journal ArticleDOI
Evolution in the Management of Aberrant Subclavian Arteries and Related Kommerell Diverticulum
Guido H.W. van Bogerijen,Himanshu J. Patel,Jonathan L. Eliason,Enrique Criado,David M. Williams,Jordan Knepper,Bo Yang,G. Michael Deeb +7 more
TL;DR: Aberrant subclavian arteries and associated Kommerell diverticulum can be treated with acceptable rates of mortality and morbidity and the evolution toward an endovascular approach did not appear to affect late outcomes, suggesting that the choice of treatment should be based on patient-specific anatomy and associated comorbidities.
Journal ArticleDOI
Propensity Adjusted Analysis of Open and Endovascular Thoracic Aortic Repair for Chronic Type B Dissection: A Twenty-Year Evaluation
Guido H.W. van Bogerijen,Himanshu J. Patel,David M. Williams,Bo Yang,Narasimham L. Dasika,Jonathan L. Eliason,G. Michael Deeb +6 more
TL;DR: Intervention for CBAD can be performed with excellent results, either by an open or endovascular approach, and the higher rate of treatment failure after TEVAR warrants modification of current device design or endOVascular approach before broad application of this treatment strategy.
Journal ArticleDOI
Contemporary Management Strategies for Chronic Type B Aortic Dissections: A Systematic Review
Arnoud V. Kamman,Arnoud V. Kamman,Hector W.L. de Beaufort,Hector W.L. de Beaufort,Guido H.W. van Bogerijen,Foeke J. H. Nauta,Foeke J. H. Nauta,Foeke J. H. Nauta,Robin H. Heijmen,Frans L. Moll,Joost A. van Herwaarden,Santi Trimarchi +11 more
TL;DR: It is found that optimal treatment of CBAD remains debatable and merits a patient specific decision, but initial experiences with B/FEVAR show its feasibility, but long-term results are needed to compare it to OSR and standard TEVAR.
Journal ArticleDOI
Predicting aortic enlargement in type B aortic dissection
Santi Trimarchi,Frederik H.W. Jonker,Guido H.W. van Bogerijen,Jip L. Tolenaar,Frans L. Moll,Martin Czerny,Himanshu J. Patel +6 more
TL;DR: This study reviewed and summarized the current available literature on prognostic variables related to aortic enlargement during follow-up in uncomplicated ABAD patients and revealed multiple factors affecting aorti expansion including demographic, clinical, pharmacologic and radiologic variables.